MORN : Summary for Morningstar, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 1 min

Morningstar, Inc. (MORN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
75.57+0.04 (+0.05%)
As of 2:58 PM EST. Market open.
People also watch:
MSMCPRTDLBIPGPNATI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close75.53
Open75.49
Bid75.68 x 100
Ask75.92 x 100
Day's Range75.22 - 75.78
52 Week Range67.74 - 89.44
Volume36,869
Avg. Volume85,507
Market Cap3.25B
Beta0.82
PE Ratio (TTM)25.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.88 (1.21%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Morningstar, Inc. – Value Analysis (NASDAQ:MORN) : December 9, 2016
    Capital Cube3 hours ago

    Morningstar, Inc. – Value Analysis (NASDAQ:MORN) : December 9, 2016

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Morningstar, Inc. a score of 66. Our analysis is based on comparing Morningstar, Inc. with the following peers – Envestnet, Inc., MSCI Inc., Thomson Reuters Corporation, S&P Global, Inc., FactSet Research Systems Inc., Value Line, Inc., Bankrate, Inc., Dun & Bradstreet Corporation, Moody’s Corporation and News Corporation ... Read more (Read more...)

  • Morningstar, Inc. breached its 50 day moving average in a Bullish Manner : MORN-US : December 8, 2016
    Capital Cubeyesterday

    Morningstar, Inc. breached its 50 day moving average in a Bullish Manner : MORN-US : December 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Morningstar, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Morningstar3 days ago

    Teva's Generics CEO Departure Cause for Concern

    Pricing pressure in the generic drug market and anticipated generic competition on the one of the narrow-moat company's main drugs in 2017 makes the abrupt leadership change a concerning development at ...